InsidersTradesSigma
Follow the 오리엔트바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 오리엔트바이오 has logged 13 public disclosures. The latest transaction was reported on 8 July 2026 (Purchase). Among the most active insiders: 오리엔트. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
13 of 13 declarations
Orient Bio is a company specializing in the health and pharmaceutical sector, listed on the XKRX. It focuses on the development and distribution of biopharmaceutical products.